Showing results (701-710 of 813) with videos related to
Sort By:
Pageof 82
Journal for Immunotherapy of Cancer|September 15, 2025
Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALLAugust A Culbert, Flavia Gava, Yannis K Valtis, et al.Diabetes Care|September 8, 2000
Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)S U Pitale, C Abraira, N V Emanuele, et al.Blood Advances|July 24, 2023
A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trialsSara K Silbert, Sanna Madan, Elizabeth M Holland, et al.Ophthalmology|November 13, 2007
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years, Michael X Repka, Danielle L Chandler, et al.The New England Journal of Medicine|October 25, 2016
Tranexamic Acid in Patients Undergoing Coronary-Artery SurgeryPaul S Myles, Julian A Smith, Andrew Forbes, et al.Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|July 4, 2008
Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age, Michael X Repka, B Michele Melia, et al.The Journal of Thoracic and Cardiovascular Surgery|November 22, 2018
Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trialPaul S Myles, Julian A Smith, Jessica Kasza, et al.Cornea|January 7, 2012
A new system, the LipiFlow, for the treatment of meibomian gland dysfunctionStephen S Lane, Harvey B DuBiner, Randy J Epstein, et al.Brain Communications|March 18, 2024
Enlarged perivascular spaces are associated with white matter injury, cognition and inflammation in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyNikolaos Karvelas, Bradley Oh, Earnest Wang, et al.Cytotherapy|December 9, 2024
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapyRoshini Traynor, Isabella Vignola, Sarmila Sarkar, et al.Pageof 82